Tang Capital Management LLC Infla Rx N.V. Transaction History

Tang Capital Management LLC

  • $1.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$1.47 - $2.03 $1.62 Million - $2.24 Million
-1,104,688 Reduced 58.96%
769,065 $1.18 Million
Q4 2023

Feb 14, 2024
SELL
$1.25 - $2.75 $1.28 Million - $2.82 Million
-1,026,247 Reduced 35.39%
1,873,753 $3.05 Million
Q2 2023

Aug 14, 2023
BUY
$2.05 - $6.1 $5.94 Million - $17.7 Million
2,900,000 New
2,900,000 $12.9 Million

Others Institutions Holding IFRX

# of Institutions
29
Shares Held
12.9M
Call Options Held
19.3K
Put Options Held
0
View Full List

About InflaRx N.V.

IFRX Quotes by TradingView
  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email